glp 1 agonist long term side effects Adverse of GLP-1 Receptor Agonists long term effects of glp-1

Liraglutide is a GLP-1 receptor agonist that is approved for managing type 2 diabetes mellitus and obesity

Cardiovasc Diabetol 19(1):156 International Diabetes Federation (2022) Brussels: International Diabetes Federation

The Weibull distribution model demonstrated that upper limits of 95% CIs of were all below 1 (Table S6), consistent with an early failure profile, indicating NAEs predominantly manifest during initial treatment phases

(2021, June 25)

Westfall, E., Jeske, R

doi: 10.3389/fphys.2022.983961 Received 01 July 2022 Accepted 07 September 2022 Published 20 September 2022 Volume 13 - 2022 Edited by Claudio de Lucia, Scientific Clinical Institute Maugeri (ICS Maugeri), Italy Reviewed by Oscar Lorenzo, Health Research Institute Foundacion Jimenez Diaz (IIS-FJD), Spain Raffaele Carraro, La Princesa University Hospital, Spain Updates Copyright 2022 Kreiner, Hovingh and von Scholten